312 results
Page 3 of 16
8-K
EX-99.1
b7th uk9s88p
11 Aug 22
Synthetic Biologics Reports Second Quarter 2022 Operational Highlights and Financial Results
8:15am
DEFA14A
EX-10.1
c5dlsmzatny4
1 Aug 22
Additional proxy soliciting materials
6:01am
DEFA14A
EX-99.1
hi7ly62v0xldkgf7
1 Aug 22
Additional proxy soliciting materials
6:01am
8-K
EX-10.1
u2k95
29 Jul 22
Synthetic Biologics Announces $3 Million Private Placement of
4:50pm
8-K
EX-99.1
x49741rs7kmi
29 Jul 22
Synthetic Biologics Announces $3 Million Private Placement of
4:50pm
8-K
EX-99.1
52ro0 10qpb
15 Jul 22
Synthetic Biologics Announces Reverse Stock Split
8:06am
8-K
EX-99.1
nk20kq5lmoqz9yacp8q
16 May 22
Synthetic Biologics Reports First Quarter 2022 Operational Highlights and Financial Results
8:05am
8-K
EX-99.1
x9iv0q
10 May 22
Synthetic Biologics Reports Positive Safety Data on SYN-020 Intestinal Alkaline Phosphatase
9:18am
8-K/A
EX-99.2
ysy zjb2ro
6 May 22
Completion of Acquisition or Disposition of Assets
5:22pm
8-K/A
EX-99.1
j2l69ef
6 May 22
Completion of Acquisition or Disposition of Assets
5:22pm
8-K
lyb4kd2n thrmbyhj8f
23 Mar 22
Synthetic Biologics Announces Management Transitions in Support of Strategic Transformation
8:30am
8-K
EX-99.1
g7rxd6np
23 Mar 22
Synthetic Biologics Announces Management Transitions in Support of Strategic Transformation
8:30am
8-K
EX-10.1
4aearg7wal v9kdr8tj
23 Mar 22
Synthetic Biologics Announces Management Transitions in Support of Strategic Transformation
8:30am
8-K
EX-99.1
allpjkojie7m km54jtk
16 Mar 22
Synthetic Biologics Reports 2021 Year End Operational Highlights and Financial Results
4:15pm
8-K
EX-99.1
hkd51 nep3
11 Mar 22
Synthetic Biologics Completes Acquisition of VCN Biosciences
8:06am
8-K
EX-99.1
g92dyv89yb8nns2a5
27 Jan 22
January 2022 B. Riley Securities Oncology Investor Conference
7:01am
8-K
iyb891
4 Jan 22
Departure of Directors or Certain Officers
5:21pm